🩺 Nirog
Bangladesh's NCD crisis is huge, under-treated, and addressable by community health workers
How Nirog closes the loop
Household → CHW visit → Screen NCDs → Manage & refer → Healthier community
A silent epidemic, mostly undiagnosed
Non-communicable disease is now the country's biggest killer, but most is caught late or never. Effective care (cheap generics + regular monitoring) doesn't need a specialist per patient — it needs safe, continuous, affordable detection and follow-up.
CHW pods, doctor-supervised
Task-shifted community health workers do household screening (BP + glucose) and ongoing follow-up under a digital protocol with doctor supervision and escalation. Each payer (employer / government) funds care for its own population at cost + margin; the poor tier is served by a separate, honestly grant-funded book — no one is asked to overpay 3×. Same task-shifting engine as Shetu.
Each payer funds its own population
One CHW pod manages ~180 chronic patients (paying + free) with a tablet, BP cuff and glucometer:
How it makes money — and what it needs to close
Needs one employer / insurer / govt NCD contract paying > 2× cost for its own population, plus clinical governance. Commission-based CHWs make the pod +31k. The payer-owns-the-population angle is the key.
employer / govt (own population)
employer NCD contracts → · generic-drug margin · govt per-patient · grant funds poor tier
employer/govt pays cost+margin for its OWN population + drug margin
employer gets a healthier workforce (fewer claims); govt gets NCD control
+31k/pod (no 3× cross-subsidy + commission CHW)
+31k/pod once you drop the unrealistic 3× cross-subsidy and pay CHWs on commission. Needs an employer/govt payer that owns the population (pays > 2× cost).
pitch an employer / insurer / govt NCD programme
Bangladesh's NCD crisis is huge, under-treated, and addressable by community health workers
COBRA-BPS (NEJM): CHW care works at <$2/capita/yr
NCDs = 67% of deaths · 61.5% of diabetics undiagnosed
The situation in Bangladesh
In Bangladesh, noncommunicable diseases now account for 67% of all deaths, and nearly one in five adults risks dying from an NCD between ages 30 and 70 1. Hypertension affects roughly a quarter of adults, yet only 36.7% are even aware they have it, just 31.1% are treated, and a mere 12.7% have it controlled 2. Diabetes tells the same story: around 13.1 million adults are affected, placing Bangladesh among the world's top 10 countries for diabetes, with nearly 5.7 million cases undiagnosed 6, and 61.5% of people with diabetes unaware of their condition 7. The gap is worst in rural areas, where undiagnosed hypertension and diabetes are widespread and regionally unequal, leaving millions to reach advanced disease before anyone detects it 59.
Our pitch
Nirog closes this detection-and-control gap by pairing trained community health workers with simple AI screening tools, mirroring the model proven in the COBRA-BPS cluster-randomized trial, where CHW-led multicomponent care lowered systolic blood pressure by about 5 mmHg more than usual care across rural Bangladesh, Pakistan and Sri Lanka 3. That same trial was highly cost-effective, projected to cost under US$2 per capita annually to scale, making door-to-door screening and chronic-care follow-up economically viable 4. Our protocols follow the WHO Package of Essential NCD interventions (PEN), explicitly designed so non-physician health workers can detect and manage cardiovascular disease and diabetes in low-resource primary care 8. The wedge is an institutional payer that funds screening and ongoing management as a cost-saving investment, because early detection and control of hypertension and diabetes is both clinically effective and cheap relative to the strokes, heart attacks and kidney failure that follow late diagnosis 34.
Built so the operator never fails
HelperChain doesn't hand out a loan and walk away. Every operator gets the full rail — inputs, training, finance, supervision, and a guaranteed buy-back of what they produce. We carry the risk so an ordinary person can succeed.
The tools, inputs and hands-on training to start — turning household into a working operation. No prior capital or expertise required.
Pay-as-you-go, riba-free finance makes a poor person a funded operator — with no debt if a cycle fails. The network carries the downside, not the operator.
Ongoing follow-up and quality assurance — the factor peer-reviewed evidence shows decides whether ventures survive (p<0.001). The operator is never left alone.
We commit to purchase the output at a fair, pre-agreed price — so there is always a market. The operator just produces; we guarantee the offtake. This is what removes the fear of failure.
A thin margin funds the next operator — so help compounds and the network grows stronger with every person it lifts.
Sources (9)
- 1.WHO (2021). NCD services in Bangladesh. WHO Results Report. link
- 2.Chowdhury, M.A.B. et al. (2021). Prevalence, awareness, treatment and control of hypertension in Bangladesh (BDHS 2017-2018). Journal of Clinical Hypertension. link
- 3.Jafar, T.H. et al. (2020). A Community-Based Intervention for Managing Hypertension in Rural South Asia (COBRA-BPS). NEJM 382:717-726. link
- 4.Krishnan, A. et al. (2021). Cost-effectiveness of the COBRA-BPS hypertension programme. BMJ Global Health. link
- 5.Hossain, M.B. et al. (2019). Inequalities in undiagnosed hypertension among Bangladeshi adults. BMC Public Health. link
- 6.International Diabetes Federation (2021). IDF Diabetes Atlas, 10th edition — Bangladesh. link
- 7.Islam, J.Y. et al. (2022). Awareness, Treatment and Control of Diabetes in Bangladesh (BDHS 2017/18). PMC. link
- 8.World Health Organization (2020). Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care. link
- 9.Mistry, S.K. et al. (2025). Prevalence and regional disparities of undiagnosed diabetes in Bangladesh (BDHS). PLOS One. link